Cite
HARVARD Citation
Hillmen, P. et al. (2016). Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL. Acta oncologica. pp. 1115-1120. [Online].